Vitamin K-dependent protein pathway

The vitamin K-dependent protein pathway refers to a set of metabolic processes in which vitamin K acts as an essential cofactor for the enzyme gamma-glutamyl carboxylase (GGCX), enabling the post-translational carboxylation of specific glutamic acid residues on vitamin K-dependent proteins (VKDPs)[1][5][7]. This reaction is critical for the biological activity of several proteins, particularly blood coagulation factors II, VII, IX, and X, as well as regulatory proteins C, S, and Z, and non-hemostatic proteins such as osteocalcin and matrix Gla protein[5][7]. The pathway involves the cellular vitamin K cycle, where vitamin K is recycled by the enzymes vitamin K epoxide reductase (VKOR) and others, making the process a repeated enzymatic circuit rather than a single static target. Deficiencies or disruptions in this pathway—genetic or drug-induced—are linked to bleeding diatheses, vascular calcification, and osteoporosis. Warfarin and related anticoagulants act by inhibiting VKOR, thereby reducing the regeneration of active vitamin K and impairing the carboxylation and function of VKDPs[5][10]. Because "vitamin K-dependent protein pathway" encompasses multiple enzymes (primarily GGCX and VKOR), structural targets (VKDPs), and cofactors (vitamin K in various forms), it cannot be treated as a single molecular drug target[5][7].

Other names

Vitamin K cycleVitamin K-dependent carboxylation pathway

Inhibition of vitamin K recycling (VKOR inhibition), Impairment of gamma-carboxylation of vitamin K-dependent proteins